Publikace
- Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic2023 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové, 3. lékařská fakulta
- Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas2022 | 1. lékařská fakulta, 2. lékařská fakulta, Lékařská fakulta v Plzni, Fakulta tělesné výchovy a sportu
- Quantitative In Vivo Monitoring of Hypoxia and Vascularization of Patient-Derived Murine Xenografts of Mantle Cell Lymphoma Using Photoacoustic and Ultrasound Imaging2021 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma2021 | 1. lékařská fakulta
- CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement2021 | 1. lékařská fakulta
- Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma2019 | 1. lékařská fakulta, 2. lékařská fakulta
- Single-agent cytarabine is insufficient for the treatment of human mantle cell lymphoma in mouse xenograft model2016 | 1. lékařská fakulta, Lékařská fakulta v Hradci Králové
- Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells2016 | 1. lékařská fakulta
- Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo2016 | 1. lékařská fakulta
- Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells2015 | 1. lékařská fakulta
Loading network view...